» Articles » PMID: 24509510

Loss of Ikaros DNA-binding Function Confers Integrin-dependent Survival on Pre-B Cells and Progression to Acute Lymphoblastic Leukemia

Overview
Journal Nat Immunol
Date 2014 Feb 11
PMID 24509510
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Deletion of the DNA-binding domain of the transcription factor Ikaros generates dominant-negative isoforms that interfere with its activity and correlate with poor prognosis in human precursor B cell acute lymphoblastic leukemia (B-ALL). Here we found that conditional inactivation of the Ikaros DNA-binding domain in early pre-B cells arrested their differentiation at a stage at which integrin-dependent adhesion to niches augmented signaling via mitogen-activated protein kinases, proliferation and self-renewal and attenuated signaling via the pre-B cell signaling complex (pre-BCR) and the differentiation of pre-B cells. Transplantation of polyclonal Ikaros-mutant pre-B cells resulted in long-latency oligoclonal pre-B-ALL, which demonstrates that loss of Ikaros contributes to multistep B cell leukemogenesis. Our results explain how normal pre-B cells transit from a highly proliferative and stroma-dependent phase to a stroma-independent phase during which differentiation is enabled, and suggest potential therapeutic strategies for Ikaros-mutant B-ALL.

Citing Articles

Comparative Profiling of Regulatory Modules as a Tool for Identifying the Transcription Factor Network Linked to Leukemogenesis.

Subramanian S, Phongbunchoo Y, Cauchy P, Ramamoorthy S Methods Mol Biol. 2025; 2909:179-209.

PMID: 40029523 DOI: 10.1007/978-1-0716-4442-3_13.


Application of Omics Analyses in Pediatric B-Cell Acute Lymphoblastic Leukemia.

Vllahu M, Savarese M, Cantiello I, Munno C, Sarcina R, Stellato P Biomedicines. 2025; 13(2).

PMID: 40002837 PMC: 11852417. DOI: 10.3390/biomedicines13020424.


Transcriptional function of E2A, Ebf1, Pax5, Ikaros and Aiolos analyzed by in vivo acute protein degradation in early B cell development.

Fedl A, Tagoh H, Gruenbacher S, Sun Q, Schenk R, Froussios K Nat Immunol. 2024; 25(9):1663-1677.

PMID: 39179932 DOI: 10.1038/s41590-024-01933-7.


A pre-B acute lymphoblastic leukemia cell line model reveals the mechanism of thalidomide therapy-related B-cell leukemogenesis.

Ramani M, Singh R, Shrivastva S, Ribeyron L, Gupta S, Roy A J Biol Chem. 2024; 300(8):107578.

PMID: 39029626 PMC: 11367411. DOI: 10.1016/j.jbc.2024.107578.


IKAROS Family Transcription Factors in Lymphocyte Differentiation and Function.

Kastner P, Chan S Adv Exp Med Biol. 2024; 1459:33-52.

PMID: 39017838 DOI: 10.1007/978-3-031-62731-6_2.


References
1.
Rolink A, Winkler T, Melchers F, Andersson J . Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. J Exp Med. 2000; 191(1):23-32. PMC: 2195801. DOI: 10.1084/jem.191.1.23. View

2.
Kersseboom R, Middendorp S, Dingjan G, Dahlenborg K, Reth M, Jumaa H . Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells. J Exp Med. 2003; 198(1):91-8. PMC: 2196076. DOI: 10.1084/jem.20030615. View

3.
Kraus M, Pao L, Reichlin A, Hu Y, Canono B, Cambier J . Interference with immunoglobulin (Ig)alpha immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igbeta cytoplasmic tail. J Exp Med. 2001; 194(4):455-69. PMC: 2193498. DOI: 10.1084/jem.194.4.455. View

4.
Georgopoulos K . Acute lymphoblastic leukemia--on the wings of IKAROS. N Engl J Med. 2009; 360(5):524-6. DOI: 10.1056/NEJMe0809819. View

5.
Iacobucci I, Storlazzi C, Cilloni D, Lonetti A, Ottaviani E, Soverini S . Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute.... Blood. 2009; 114(10):2159-67. DOI: 10.1182/blood-2008-08-173963. View